MNPR
NASDAQ · Biotechnology
Monopar Therapeutics Inc
$55.21
-3.46 (-5.90%)
Analyst Consensus
Strong Buy
20
Analysts
High
Coverage
Price Target
Analyst Price Target
-25.2% upside
Low Target
$22.89
Average Target
$41.31
High Target
$45.20
Current Price
$55.21
Current
$55.21
$55.21
Target
$41.31
$41.31
$22.89
$41.31 avg
$45.20
Scenario Analysis
Bear Case
$22.89
-58.5%
Low target
Base Case
$41.31
-25.2%
Avg target
Bull Case
$45.20
+-18.1%
High target
Risk/Reward
0.3x
Unfavorable
Price in Context
52-Week High
$105.00
-47.4% from high
52-Week Low
$26.06
+111.9% from low
Target vs 52W High
$41.31
-60.7% vs high
Next Earnings Report
Mar 30, 2026 · After Market Close
3d
until earnings
EPS Est: $-0.50
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Buy | 39 | 69% | $257.58 | +24.3% |
| AMGN | Hold | 42 | 50% | $190.87 | -46.1% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +162.3% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | -3.7% |
| REGN | Strong Buy | 36 | 75% | $76.80 | -89.8% |
| ALNY | Strong Buy | 36 | 78% | $102.31 | -68.9% |
| INSM | Strong Buy | 26 | 92% | $143.40 | -3.3% |
| NTRA | Strong Buy | 27 | 89% | $142.91 | -27.6% |